« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 4
, Pages 840-845
, April 2009
Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: A multicenter analysis
References
- Society of Thoracic Sugeons. Spring 2007 Report–Adult Cardiac Database Executive Summary. 2007 [cited 2007 Sept 27]; Available from http://www.sts.org/sections/stsnationaldatabase/publications/executive/article.html.
- ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures. J Am Coll Cardiol. 2007;50:82–108
- . Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet. 2002;360:965–970
- . First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). Lancet. 1995;346:1179–1184
- Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005;352:2174–2183
- Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI. Analysis of BARI like patients in northern New England. Circulation. 2005;112(suppl I):I371–I376
- Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008;358:342–352
- CABG after successful PTCA: a case-control study. Ann Thorac Surg. 1995;59:1391–1396
- Outcome of patients with prior percutaneous revascularisation undergoing repeat coronary intervention (from the PRESTO trial). Am J Cardiol. 2005;96:741–746
- Prognostic significance of multiple previous percutaneous interventions in patients undergoing elective coronary artery bypass surgery. Circulation. 2006;114(suppl I):I441–I447
- Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2007;134:470–476
- Does previous percutaneous coronary stenting compromise the long-term efficacy of subsequent coronary artery bypass surgery? A microsimulation study. Ann Thorac Surg. 2008;85:501–507
- for the IMAGINE investigators. Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularisation on outcomes after surgical revascularisation: insights from the IMAGINE study. Eur Heart J. 2008;29:573–575
- . Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–2281
- . Improved odds ratio estimation by post hoc stratification of case–control data. Stat Med. 1997;16:993–1004
- Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation. 1998;98:2370–2376
- . Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J. 2004;25:1679–1687
- Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation. 2002;106:2180–2183
- . Morphologic predictors of restenosis after coronary stenting in humans. Circulation. 2002;105:2974–2980
- . Coronary stenting and inflammation: implications for further surgical and medical treatment. Ann Thorac Surg. 2006;81:1918–1925
- Long-term patency of saphenous vein and left internal mammary artery grafts after coronary bypass surgery. J Am Coll Cardiol. 2004;44:2149–2156
- Fate of stent-related side branches after coronary intervention in patients with in-stent restenosis. J Am Coll Cardiol. 2000;36:1549–1556
- Prognostic significance of elevated troponin I after percutaneous coronary interventions. J Am Coll Cardiol. 2002;39:1738–1744
- Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation. 2005;111:1027–1032
- . Coronary revascularisation. BMJ. 2007;344:593–594
- Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation. 2007;116:745–754
- Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008;135:732–738
- . The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354:353–365
- . Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. Ann Thorac Surg. 2006;82:1966–1975
- Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non randomised multicentre trial. Lancet. 2007;369:1869–1875
Drs Massoudy and Thielmann equally contributed to this work.
PII: S0022-5223(08)01493-1
doi: 10.1016/j.jtcvs.2008.09.005
© 2009 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Thoracic and Cardiovascular Surgery
Volume 137, Issue 4
, Pages 840-845
, April 2009
